A new analysis found that acute anemia in patients who had a heart attack is associated with a higher risk of death or recurrent myocardial infarction at 30 days.
This phase 3 study demonstrated that roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is noninferior to rHuEPO-α in improving hemoglobin levels for chemotherapy-induced anemia,...
Mary is a 34-year-old G2P2 woman with idiopathic menorrhagia. For the past 15 years, she has experienced prolonged menses (≥ 8 days) requiring 7 to 10 pads/d.
In this podcast, Allan Platt, PA-C, MMSc, discusses how to identify and diagnose anemia in a primary care setting, a topic he presented at the 2021 American Academy of Physician Assistants conference. ...
